查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1980189

医疗保健领域认知功能评估与训练市场：规模、份额、成长及全球产业分析：按类型、应用和地区划分，并预测至2026-2034年

Cognitive Assessment and Training in Healthcare Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 152 Pages | 商品交期: 请询问到货日

价格

医疗领域认知功能评估与训练市场的成长要素

2025年，全球医疗保健领域的认知功能评估和训练市场规模为59.1亿美元。预计该市场将从2026年的68.5亿美元成长至2034年的263.2亿美元，在预测期内（2026-2034年）维持19.50%的强劲复合年增长率。北美市场占据主导地位，在2025年占据56.40%的市场份额，这主要得益于数位认知工具的普及应用和监管核准的推进。

认知功能评估和训练工具旨在评估心理功能，并辅助诊断阿兹海默症、失智症、轻度认知障碍 (MCI)、忧郁症和其他认知障碍等神经系统疾病。这些工具可帮助医疗专业人员及早发现认知衰退，并在治疗和临床试验期间监测患者的进展。

市场驱动因素

神经系统疾病盛行率增加

神经系统疾病负担日益加重是成长要素。在全球范围内，轻度认知障碍（MCI）的盛行率约为15-20%，而失智症影响全球数百万人口。光是在美国，就有约670万65岁及以上的老年人患有阿兹海默症。人们对早期诊断和认知功能筛检的日益重视，正在加速对数位化和传统评估工具的需求。

扩大神经系统疾病临床试验

针对阿兹海默症和其他神经系统疾病的临床试验规模不断扩大，显着推动了市场成长。近期全球数据显示，目前有超过160项临床试验正在进行，评估超过120种阿兹海默症候选药物。认知功能评估工具对于监测治疗效果和患者认知功能的变化至关重要。对远端和即时认知功能监测日益增长的需求，正在推动数位化平台的应用。

市场趋势

扩大分散式和虚拟临床试验的应用

新冠疫情加速了去中心化临床试验（DCT）的转型。虚拟临床试验利用远端患者监护、穿戴式装置和线上认知功能评估。这些模式提高了患者参与度和资料收集效率。

数位化认知工具使患者能够远端完成评估，研究人员无需亲临现场即可监测结果。这种便利性显着加速了数位化认知解决方案在医学领域的应用，尤其是在大规模神经学研究中。

抑制因子

儘管成长迅速，但仍存在一些挑战限制了市场扩张。认知功能评估套装的高成本（某些地区为600至1200美元）是其普及的一大障碍。此外，人们对MoCA等标准化测试的准确性和临界值的担忧可能导致误诊。这些限制可能会减缓该技术的推广应用，尤其是在开发中国家。

市场区隔分析

按评估类型

从市场区隔的角度来看，它可以分为纸笔认证、生物识别和託管解决方案。

到2026年，纸笔评估方式将以46.58%的市占率占据主导地位，这主要归功于其成本效益以及与人工智慧分析工具的整合。新兴的基于人工智慧的绘图测试正在提高诊断准确性。

受数位生物标记和先进神经监测技术的日益普及的推动，生物识别领域预计将以最高的复合年增长率成长。

透过使用

从应用领域来看，市场包括筛检和诊断、临床试验和脑力训练。

到2026年，临床试验领域将以43.22%的市场份额引领市场，这主要得益于旨在简化认知功能评估的产品上市数量的增加。不断扩充的阿兹海默症治疗开发平臺也将继续支撑这一领域。

预计筛检和诊断领域将经历最快的成长，这得益于人们意识的提高以及为提供数位化认知筛检解决方案而扩大的伙伴关係。

区域趋势

北美洲

预计北美市场规模将在2025年达到33.3亿美元，并在2026年成长至39.2亿美元。美国市场预计在2026年达到37.1亿美元。这一增长主要得益于FDA对数位认知工具的核准、研发投入的增加以及神经系统疾病的高发生率。

欧洲

预计欧洲在预测期内将实现最高成长率。英国市场预计到2026年将达到4.8亿美元，德国市场预计2026年将达到6.1亿美元。主要企业的强大实力和对早期诊断日益增长的需求是推动该地区成长的主要因素。

亚太地区

亚太地区预计将迎来显着成长。到2026年，日本市场规模预计将达到1.5亿美元，中国市场达到1.9亿美元，印度市场达到7,000万美元。拓展策略伙伴关係和提升品牌知名度是推动这一成长的主要动力。

在包括拉丁美洲、中东和非洲在内的世界其他地区，由于医疗基础设施的改善和宣传活动的开展，预计将保持稳定成长。

目录

第一章：引言

第二章执行摘要

第三章 市场动态

  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场趋势

第四章：主要考虑因素

  • 2025年主要国家进行的临床试验数量
  • 2025年主要国家轻度认知障碍（MCI）盛行率
  • 产业重大发展动态（合併、收购、合作等）
  • 新冠疫情对市场的影响

第五章：2021-2034年全球医疗保健产业认知功能评估与训练市场分析、洞察与预测

  • 市场分析、洞察与预测：按评估类型划分
    • 纸和笔
    • 生物识别
    • 託管
  • 市场分析、洞察与预测：按应用领域划分
    • 筛检和诊断
    • 临床试验
    • 脑力训练
    • 其他的
  • 市场分析、洞察与预测：按地区划分
    • 北美洲
    • 欧洲
    • 亚太地区
    • 世界其他地区

第六章：北美医疗保健认知功能评估与训练市场分析、洞察与预测（2021-2034年）

  • 国家
    • 我们
    • 加拿大

第七章：欧洲医疗保健认知评估与训练市场分析、洞察与预测（2021-2034年）

  • 国家
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 斯堪地那维亚
    • 其他欧洲国家

第八章：亚太医疗保健产业认知功能评估与训练市场分析、洞察与预测（2021-2034年）

  • 国家
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 东南亚
    • 其他亚太国家

第九章：2021-2034年全球医疗保健产业认知功能评估与训练市场分析、洞察与预测

第十章 竞争分析

  • 全球市占率分析（2025 年）
  • 公司简介
    • Cambridge Cognition Ltd
    • CogniFit Inc
    • Cogstate Ltd.
    • CNS Vital Signs, LLC.
    • WIRB-Copernicus Group
    • Signant Health
    • Posit Science
    • Clario
    • Cognetivity Neurosciences
    • Linus Health
    • Par Inc.
    • KERNEL
    • Neurotrack Technologies, Inc.
    • Pearson
    • Koninklijke Philips NV
    • Winterlight Labs
    • Aural Analytics
Product Code: FBI107441

Growth Factors of cognitive assessment and training in healthcare Market

The global cognitive assessment and training in healthcare market size was valued at USD 5.91 billion in 2025. The market is projected to grow from USD 6.85 billion in 2026 to USD 26.32 billion by 2034, registering a robust CAGR of 19.50% during the forecast period (2026-2034). North America dominated the market with a 56.40% share in 2025, driven by strong technological adoption and regulatory approvals for digital cognitive tools.

Cognitive assessment and training tools are designed to evaluate mental functioning and help diagnose neurological disorders such as Alzheimer's disease, dementia, mild cognitive impairment (MCI), depression, and other cognitive conditions. These tools assist healthcare professionals in detecting early cognitive decline and monitoring patient progress during treatment and clinical trials.

Market Drivers

Rising Prevalence of Neurological Disorders

The growing burden of neurological disorders is a primary growth driver. The prevalence of MCI globally stands at approximately 15-20%, while dementia affects millions worldwide. In the U.S. alone, around 6.7 million individuals aged 65 and above were living with Alzheimer's disease. Increasing awareness of early diagnosis and cognitive screening has accelerated demand for digital and traditional assessment tools.

Growth in Clinical Trials for Neurological Diseases

The expansion of clinical trials for Alzheimer's and other neurological conditions significantly fuels market growth. As of recent global data, over 160 clinical trials assessing more than 120 drug candidates for Alzheimer's disease are underway. Cognitive assessment tools are critical in monitoring treatment effectiveness and cognitive changes in enrolled patients. The growing requirement for remote and real-time cognitive monitoring strengthens the adoption of digital platforms.

Market Trends

Rising Adoption of Decentralized and Virtual Clinical Trials

The COVID-19 pandemic accelerated the shift toward decentralized clinical trials (DCTs). Virtual trials utilize remote patient monitoring, wearable devices, and online cognitive assessments. These models improve patient participation and data collection efficiency.

Digital cognitive tools allow patients to complete assessments remotely, enabling researchers to monitor outcomes without in-person visits. This convenience has significantly boosted the integration of digital cognitive solutions in healthcare, especially in large-scale neurological studies.

Restraining Factors

Despite rapid growth, certain challenges limit market expansion. The high cost of cognitive assessment packages-ranging between USD 600 and USD 1,200 in some regions-restricts accessibility. Additionally, concerns about accuracy and cut-off scoring in standardized tests such as MoCA may result in misdiagnosis. These limitations may slow adoption, particularly in developing economies.

Market Segmentation Analysis

By Assessment Type

The market is segmented into pen and paper, biometrics, and hosted solutions.

The pen and paper segment dominated in 2026 with a 46.58% share, primarily due to cost-effectiveness and integration with AI-powered analysis tools. Emerging AI-enhanced drawing-based tests are improving diagnostic accuracy.

The biometrics segment is expected to grow at the fastest CAGR due to increasing use of digital biomarkers and advanced neurological monitoring technologies.

By Application

Based on application, the market includes screening & diagnostics, clinical trials, brain training, and others.

The clinical trials segment led the market with a 43.22% share in 2026, driven by increasing product launches aimed at improving cognitive assessment efficiency. Growing Alzheimer's drug development pipelines continue to support this segment.

The screening and diagnostics segment is projected to witness the fastest growth due to increased awareness and partnerships offering digital cognitive screening solutions.

Regional Insights

North America

North America accounted for USD 3.33 billion in 2025 and grew to USD 3.92 billion in 2026. The U.S. market reached USD 3.71 billion in 2026. Growth is supported by FDA approvals of digital cognitive tools, increasing R&D investments, and high prevalence of neurological diseases.

Europe

Europe is expected to record the fastest growth rate during the forecast period. The UK market reached USD 0.48 billion in 2026, while Germany accounted for USD 0.61 billion in 2026. Strong presence of leading companies and increasing demand for early diagnosis drive regional growth.

Asia Pacific

Asia Pacific is projected to grow substantially. Japan's market reached USD 0.15 billion in 2026, China accounted for USD 0.19 billion in 2026, and India reached USD 0.07 billion in 2026. Expanding strategic partnerships and rising awareness are key growth contributors.

The Rest of the World, including Latin America and the Middle East & Africa, is expected to show steady growth due to improving healthcare infrastructure and awareness initiatives.

Competitive Landscape

Prominent players include Cambridge Cognition Ltd, Pearson, Cogstate Ltd, PAR, Inc., CogniFit Inc., Clario, Signant Health, and Koninklijke Philips N.V. Companies are strengthening market positions through acquisitions, partnerships, and AI-based product launches. Strategic collaborations and digital innovation remain central to competitive advantage.

Conclusion

The cognitive assessment and training in healthcare market is poised for remarkable expansion, growing from USD 5.91 billion in 2025 to USD 26.32 billion by 2034, at a CAGR of 19.50%. Increasing neurological disease prevalence, rising clinical trial activity, and rapid digital transformation in healthcare are major growth drivers. While high costs and assessment limitations pose challenges, technological advancements and decentralized trial adoption are expected to offset these barriers. North America remains the dominant region, while Europe and Asia Pacific offer significant growth opportunities. Continuous innovation and global expansion strategies will be crucial for sustained market leadership through 2034.

Segmentation By Assessment Type

  • Pen and Paper
  • Biometrics
  • Hosted

By Application

  • Screening and Diagnostics
  • Clinical Trials
  • Brain Training
  • Others

By Region

  • North America (By Assessment Type, Application, and Country)
    • U.S.
    • Canada
  • Europe (By Assessment Type, Application, and Country/Sub-region)
    • U.K.
    • Germany
    • France
    • Spain
    • Italy
    • Scandinavia
    • Rest of Europe
  • Asia Pacific (By Assessment Type, Application, and Country/Sub-region)
    • China
    • India
    • Japan
    • Australia
    • Southeast Asia
    • Rest of Asia Pacific
  • Rest of the World (By Assessment Type, Application)

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Number of Clinical Trials Conducted - by Key Countries, 2025
  • 4.2. Prevalence of Mild Cognitive Impairment (MCI) - by Key Countries, 2025
  • 4.3. Key Industry Developments (Mergers, Acquisitions, Partnerships; etc.)
  • 4.4. Impact of COVID-19 on the Market

5. Global Cognitive Assessment and Training in Healthcare Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Assessment Type
    • 5.1.1. Pen and Paper
    • 5.1.2. Biometrics
    • 5.1.3. Hosted
  • 5.2. Market Analysis, Insights and Forecast - By Application
    • 5.2.1. Screening and Diagnostics
    • 5.2.2. Clinical Trials
    • 5.2.3. Brain Training
    • 5.2.4. Others
  • 5.3. Market Analysis, Insights and Forecast - By Region
    • 5.3.1. North America
    • 5.3.2. Europe
    • 5.3.3. Asia Pacific
    • 5.3.4. Rest of the World

6. North America Cognitive Assessment and Training in Healthcare Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Assessment Type
    • 6.1.1. Pen and Paper
    • 6.1.2. Biometrics
    • 6.1.3. Hosted
  • 6.2. Market Analysis, Insights and Forecast - By Application
    • 6.2.1. Screening and Diagnostics
    • 6.2.2. Clinical Trials
    • 6.2.3. Brain Training
    • 6.2.4. Others
  • 6.3. Market Analysis, Insights and Forecast - By Country
    • 6.3.1. U.S.
    • 6.3.2. Canada

7. Europe Cognitive Assessment and Training in Healthcare Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Assessment Type
    • 7.1.1. Pen and Paper
    • 7.1.2. Biometrics
    • 7.1.3. Hosted
  • 7.2. Market Analysis, Insights and Forecast - By Application
    • 7.2.1. Screening and Diagnostics
    • 7.2.2. Clinical Trials
    • 7.2.3. Brain Training
    • 7.2.4. Others
  • 7.3. Market Analysis, Insights and Forecast - By Country/Sub-Region
    • 7.3.1. Germany
    • 7.3.2. U.K.
    • 7.3.3. France
    • 7.3.4. Italy
    • 7.3.5. Spain
    • 7.3.6. Scandinavia
    • 7.3.7. Rest of Europe

8. Asia Pacific Cognitive Assessment and Training in Healthcare Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Assessment Type
    • 8.1.1. Pen and Paper
    • 8.1.2. Biometrics
    • 8.1.3. Hosted
  • 8.2. Market Analysis, Insights and Forecast - By Application
    • 8.2.1. Screening and Diagnostics
    • 8.2.2. Clinical Trials
    • 8.2.3. Brain Training
    • 8.2.4. Others
  • 8.3. Market Analysis, Insights and Forecast - By Country/Sub-Region
    • 8.3.1. China
    • 8.3.2. Japan
    • 8.3.3. India
    • 8.3.4. Australia
    • 8.3.5. Southeast Asia
    • 8.3.6. Rest of Asia Pacific

9. Rest of the World Cognitive Assessment and Training in Healthcare Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Assessment Type
    • 9.1.1. Pen and Paper
    • 9.1.2. Biometrics
    • 9.1.3. Hosted
  • 9.2. Market Analysis, Insights and Forecast - By Application
    • 9.2.1. Screening and Diagnostics
    • 9.2.2. Clinical Trials
    • 9.2.3. Brain Training
    • 9.2.4. Others

10. Competitive Analysis

  • 10.1. Global Market Share Analysis (2025)
  • 10.2. Company Profiles
    • 10.2.1. Cambridge Cognition Ltd
      • 10.2.1.1. Overview
      • 10.2.1.2. Products
      • 10.2.1.3. SWOT Analysis
      • 10.2.1.4. Recent Developments
      • 10.2.1.5. Strategies
      • 10.2.1.6. Financials (Based on Availability)
    • 10.2.2. CogniFit Inc
      • 10.2.2.1. Overview
      • 10.2.2.2. Products
      • 10.2.2.3. SWOT Analysis
      • 10.2.2.4. Recent Developments
      • 10.2.2.5. Strategies
      • 10.2.2.6. Financials (Based on Availability)
    • 10.2.3. Cogstate Ltd.
      • 10.2.3.1. Overview
      • 10.2.3.2. Products
      • 10.2.3.3. SWOT Analysis
      • 10.2.3.4. Recent Developments
      • 10.2.3.5. Strategies
      • 10.2.3.6. Financials (Based on Availability)
    • 10.2.4. CNS Vital Signs, LLC.
      • 10.2.4.1. Overview
      • 10.2.4.2. Products
      • 10.2.4.3. SWOT Analysis
      • 10.2.4.4. Recent Developments
      • 10.2.4.5. Strategies
      • 10.2.4.6. Financials (Based on Availability)
    • 10.2.5. WIRB-Copernicus Group
      • 10.2.5.1. Overview
      • 10.2.5.2. Products
      • 10.2.5.3. SWOT Analysis
      • 10.2.5.4. Recent Developments
      • 10.2.5.5. Strategies
      • 10.2.5.6. Financials (Based on Availability)
    • 10.2.6. Signant Health
      • 10.2.6.1. Overview
      • 10.2.6.2. Products
      • 10.2.6.3. SWOT Analysis
      • 10.2.6.4. Recent Developments
      • 10.2.6.5. Strategies
      • 10.2.6.6. Financials (Based on Availability)
    • 10.2.7. Posit Science
      • 10.2.7.1. Overview
      • 10.2.7.2. Products
      • 10.2.7.3. SWOT Analysis
      • 10.2.7.4. Recent Developments
      • 10.2.7.5. Strategies
      • 10.2.7.6. Financials (Based on Availability)
    • 10.2.8. Clario
      • 10.2.8.1. Overview
      • 10.2.8.2. Products
      • 10.2.8.3. SWOT Analysis
      • 10.2.8.4. Recent Developments
      • 10.2.8.5. Strategies
      • 10.2.8.6. Financials (Based on Availability)
    • 10.2.9. Cognetivity Neurosciences
      • 10.2.9.1. Overview
      • 10.2.9.2. Products
      • 10.2.9.3. SWOT Analysis
      • 10.2.9.4. Recent Developments
      • 10.2.9.5. Strategies
      • 10.2.9.6. Financials (Based on Availability)
    • 10.2.10. Linus Health
      • 10.2.10.1. Overview
      • 10.2.10.2. Products
      • 10.2.10.3. SWOT Analysis
      • 10.2.10.4. Recent Developments
      • 10.2.10.5. Strategies
      • 10.2.10.6. Financials (Based on Availability)
    • 10.2.11. Par Inc.
      • 10.2.11.1. Overview
      • 10.2.11.2. Products
      • 10.2.11.3. SWOT Analysis
      • 10.2.11.4. Recent Developments
      • 10.2.11.5. Strategies
      • 10.2.11.6. Financials (Based on Availability)
    • 10.2.12. KERNEL
      • 10.2.12.1. Overview
      • 10.2.12.2. Products
      • 10.2.12.3. SWOT Analysis
      • 10.2.12.4. Recent Developments
      • 10.2.12.5. Strategies
      • 10.2.12.6. Financials (Based on Availability)
    • 10.2.13. Neurotrack Technologies, Inc.
      • 10.2.13.1. Overview
      • 10.2.13.2. Products
      • 10.2.13.3. SWOT Analysis
      • 10.2.13.4. Recent Developments
      • 10.2.13.5. Strategies
      • 10.2.13.6. Financials (Based on Availability)
    • 10.2.14. Pearson
      • 10.2.14.1. Overview
      • 10.2.14.2. Products
      • 10.2.14.3. SWOT Analysis
      • 10.2.14.4. Recent Developments
      • 10.2.14.5. Strategies
      • 10.2.14.6. Financials (Based on Availability)
    • 10.2.15. Koninklijke Philips N.V.
      • 10.2.15.1. Overview
      • 10.2.15.2. Products
      • 10.2.15.3. SWOT Analysis
      • 10.2.15.4. Recent Developments
      • 10.2.15.5. Strategies
      • 10.2.15.6. Financials (Based on Availability)
    • 10.2.16. Winterlight Labs
      • 10.2.16.1. Overview
      • 10.2.16.2. Products
      • 10.2.16.3. SWOT Analysis
      • 10.2.16.4. Recent Developments
      • 10.2.16.5. Strategies
      • 10.2.16.6. Financials (Based on Availability)
    • 10.2.17. Aural Analytics
      • 10.2.17.1. Overview
      • 10.2.17.2. Products
      • 10.2.17.3. SWOT Analysis
      • 10.2.17.4. Recent Developments
      • 10.2.17.5. Strategies
      • 10.2.17.6. Financials (Based on Availability)

List of Tables

  • Table 1: Global Cognitive Assessment and Training in Healthcare Market Revenue (USD billion) Forecast, by Assessment Type, 2021-2034
  • Table 2: Global Cognitive Assessment and Training in Healthcare Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 3: Global Cognitive Assessment and Training in Healthcare Market Revenue (USD billion) Forecast, by Region, 2021-2034
  • Table 4: North America Cognitive Assessment and Training in Healthcare Market Revenue (USD billion) Forecast, by Assessment Type, 2021-2034
  • Table 5: North America Cognitive Assessment and Training in Healthcare Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 6: North America Cognitive Assessment and Training in Healthcare Market Revenue (USD billion) Forecast, By Country, 2021-2034
  • Table 7: Europe Cognitive Assessment and Training in Healthcare Market Revenue (USD billion) Forecast, by Assessment Type, 2021-2034
  • Table 8: Europe Cognitive Assessment and Training in Healthcare Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 9: Europe Cognitive Assessment and Training in Healthcare Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 10: Asia Pacific Cognitive Assessment and Training in Healthcare Market Revenue (USD billion) Forecast, by Assessment Type, 2021-2034
  • Table 11: Asia Pacific Cognitive Assessment and Training in Healthcare Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 12: Asia Pacific Cognitive Assessment and Training in Healthcare Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 13: Rest of the World Cognitive Assessment and Training in Healthcare Market Revenue (USD billion) Forecast, by Assessment Type, 2021-2034
  • Table 14: Rest of the World Cognitive Assessment and Training in Healthcare Market Revenue (USD billion) Forecast, by Application, 2021-2034

List of Figures

  • Figure 1: Global Cognitive Assessment and Training in Healthcare Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034
  • Figure 2: Global Cognitive Assessment and Training in Healthcare Market Value Share (%), by Assessment Type, 2025 & 2034
  • Figure 3: Global Cognitive Assessment and Training in Healthcare Market Value Share (%), by Application, 2025 & 2034
  • Figure 4: Global Cognitive Assessment and Training in Healthcare Market Value (USD billion), by Region, 2025 & 2034
  • Figure 5: North America Cognitive Assessment and Training in Healthcare Market Value (USD billion), by Assessment Type, 2025 & 2034
  • Figure 6: North America Cognitive Assessment and Training in Healthcare Market Value Share (%), by Assessment Type, 2025
  • Figure 7: North America Cognitive Assessment and Training in Healthcare Market Value (USD billion), by Application, 2025 & 2034
  • Figure 8: North America Cognitive Assessment and Training in Healthcare Market Value Share (%), by Application, 2025
  • Figure 9: North America Cognitive Assessment and Training in Healthcare Market Value (USD billion), By Country, 2025 & 2034
  • Figure 10: North America Cognitive Assessment and Training in Healthcare Market Value Share (%), By Country, 2025
  • Figure 11: Europe Cognitive Assessment and Training in Healthcare Market Value (USD billion), by Assessment Type, 2025 & 2034
  • Figure 12: Europe Cognitive Assessment and Training in Healthcare Market Value Share (%), by Assessment Type, 2025
  • Figure 13: Europe Cognitive Assessment and Training in Healthcare Market Value (USD billion), by Application, 2025 & 2034
  • Figure 14: Europe Cognitive Assessment and Training in Healthcare Market Value Share (%), by Application, 2025
  • Figure 15: Europe Cognitive Assessment and Training in Healthcare Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 16: Europe Cognitive Assessment and Training in Healthcare Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 17: Asia Pacific Cognitive Assessment and Training in Healthcare Market Value (USD billion), by Assessment Type, 2025 & 2034
  • Figure 18: Asia Pacific Cognitive Assessment and Training in Healthcare Market Value Share (%), by Assessment Type, 2025
  • Figure 19: Asia Pacific Cognitive Assessment and Training in Healthcare Market Value (USD billion), by Application, 2025 & 2034
  • Figure 20: Asia Pacific Cognitive Assessment and Training in Healthcare Market Value Share (%), by Application, 2025
  • Figure 21: Asia Pacific Cognitive Assessment and Training in Healthcare Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 22: Asia Pacific Cognitive Assessment and Training in Healthcare Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 23: Rest of the World Cognitive Assessment and Training in Healthcare Market Value (USD billion), by Assessment Type, 2025 & 2034
  • Figure 24: Rest of the World Cognitive Assessment and Training in Healthcare Market Value Share (%), by Assessment Type, 2025
  • Figure 25: Rest of the World Cognitive Assessment and Training in Healthcare Market Value (USD billion), by Application, 2025 & 2034
  • Figure 26: Rest of the World Cognitive Assessment and Training in Healthcare Market Value Share (%), by Application, 2025
  • Figure 27: Global Cognitive Assessment and Training in Healthcare Market Share (%), By Company, 2025